Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma

References

• Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-Oncology. 2013;15(Suppl 2):ii1–ii56. doi:10.1093/neuonc/not15124137015
   PubMed Web of Science ®Google Scholar
• Claus EB, Walsh KM, Wiencke JK, et al. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 2015;38(1):E6. doi:10.3171/2014.10.FOCUS12367
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N; Brat DJ, Verhaak RG, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481–2498. doi:10.1056/NEJMoa1402121.26061751
   PubMed Web of Science ®Google Scholar
• Vogelbaum MA, Hu C, Peereboom DM, et al. Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131. J Neurooncol. 2015;124(3):413–420. doi:10.1007/s11060-015-1845-726088460
   PubMed Web of Science ®Google Scholar
• Payne CM, Crowley-Skillicorn C, Bernstein C, Holubec H, Bernstein H. Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis. Clin Exp Gastroenterol. 2011;4:75–119. doi:10.2147/CEG.S1711421753893
   PubMedGoogle Scholar
• Li H, Da LJ, Fan WD, Long XH, Zhang XQ. Transcription factor glioma-associated oncogene homolog 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition of non-small cell lung cancer cells. Mol Med Rep. 2015;11(5):3259–3268. doi:10.3892/mmr.2015.315025586417
   PubMed Web of Science ®Google Scholar
• Gregory SG, Barlow KF, McLay KE, et al. The DNA sequence and biological annotation of human chromosome 1. Nature. 2006;441(7091):315–321. doi:10.1038/nature0472716710414
   PubMed Web of Science ®Google Scholar
• Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499–2508. doi:10.1056/NEJMoa140727926061753
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.050658010216199517
   PubMed Web of Science ®Google Scholar
• Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–1740. doi:10.1093/bioinformatics/btr26021546393
   PubMed Web of Science ®Google Scholar
• Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3 Article3. doi:10.2202/1544-6115.1018
   PubMedGoogle Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi:10.1186/1471-2105-12-7721414208
   PubMed Web of Science ®Google Scholar
• Gerds TA, Kattan MW, Schumacher M, Yu C. Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Stat Med. 2013;32(13):2173–2184. doi:10.1002/sim.568123172755
   PubMed Web of Science ®Google Scholar
• Chen B, Liang T, Yang P, et al. Classifying lower grade glioma cases according to whole genome gene expression. Oncotarget. 2016;7(45):74031–74042. doi:10.18632/oncotarget.1218827677590
   PubMedGoogle Scholar
• Zhang C, Li J, Wang H, Song SW. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Oncotarget. 2016;7(45):73971–73983. doi:10.18632/oncotarget.1260527738332
   PubMedGoogle Scholar
• Bao ZS, Li MY, Wang JY, et al. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. CNS Neurosci Ther. 2014;20(2):112–118. doi:10.1111/cns.1217124279471
   PubMed Web of Science ®Google Scholar
• Kannan K, Inagaki A, Silber J, et al. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget. 2012;3(10):1194–1203. doi:10.18632/oncotarget.68923104868
   PubMed Web of Science ®Google Scholar
• Chan AK, Yao Y, Zhang Z, et al. TERT promoter mutations contribute to subset prognostication of lower-grade gliomas. Mod Pathol. 2015;28(2):177–186. doi:10.1038/modpathol.2014.9425081751
   PubMed Web of Science ®Google Scholar
• Sahm F, Koelsche C, Meyer J, et al. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol. 2012;123(6):853–860. doi:10.1007/s00401-012-0993-522588899
   PubMed Web of Science ®Google Scholar
• Chan AK, Pang JC, Chung NY, et al. Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors. Mod Pathol. 2014;27(3):332–342. doi:10.1038/modpathol.2013.16524030748
   PubMed Web of Science ®Google Scholar
• Sabha N, Knobbe CB, Maganti M, et al. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Neuro-Oncology. 2014;16(7):914–923. doi:10.1093/neuonc/not29924470545
   PubMed Web of Science ®Google Scholar
• Jiang H, Ren X, Cui X, et al. 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. Neuro-Oncology. 2013;15(6):775–782. doi:10.1093/neuonc/not02723486687
   PubMed Web of Science ®Google Scholar
• Kouwenhoven MC, Gorlia T, Kros JM, et al. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: a report from EORTC study 26951. Neuro-Oncology. 2009;11(6):737–746. doi:10.1215/15228517-2009-01119224764
   PubMed Web of Science ®Google Scholar
• Minniti G, Arcella A, Scaringi C, et al. Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers. J Neurooncol. 2014;116(2):275–282. doi:10.1007/s11060-013-1288-y24162810
   PubMed Web of Science ®Google Scholar
• Frenel JS, Leux C, Loussouarn D, et al. Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. J Neurooncol. 2013;114(1):85–91. doi:10.1007/s11060-013-1152-023681562
   PubMed Web of Science ®Google Scholar
• Grimwood J, Gordon LA, Olsen A, et al. The DNA sequence and biology of human chromosome 19. Nature. 2004;428(6982):529–535. doi:10.1038/nature0239915057824
   PubMed Web of Science ®Google Scholar
• Gill RK, Yang SH, Meerzaman D, et al. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene. 2011;30(35):3784–3791. doi:10.1038/onc.2011.9821532627
   PubMed Web of Science ®Google Scholar
• Xiao M, Xiao S, Straaten TV, et al. Genetic polymorphisms in 19q13.3 genes associated with alteration of repair capacity to BPDE-DNA adducts in primary cultured lymphocytes. Mutat Res. 2016;812:39–47. doi:10.1016/j.mrgentox.2016.10.00427908386
   PubMed Web of Science ®Google Scholar
• Mantovani F, Tocco F, Girardini J, et al. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol. 2007;14(10):912–920. doi:10.1038/nsmb130617906639
   PubMed Web of Science ®Google Scholar
• Manning AL, Ganem NJ, Bakhoum SF, Wagenbach M, Wordeman L, Compton DA. The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell. 2007;18(8):2970–2979. doi:10.1091/mbc.e07-02-011017538014
   PubMed Web of Science ®Google Scholar
• Bie L, Zhao G, Wang YP, Zhang B. Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas. Clin Neurol Neurosurg. 2012;114(4):356–360. doi:10.1016/j.clineuro.2011.11.00522130050
   PubMed Web of Science ®Google Scholar
• Hallen LC, Burki Y, Ebeling M, et al. Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J Interferon Cytokine Res. 2007;27(8):675–680. doi:10.1089/jir.2007.002117784819
   PubMed Web of Science ®Google Scholar
• Power D, Santoso N, Dieringer M, et al. IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency. Virology. 2015;481:142–150. doi:10.1016/j.virol.2015.02.04625776761
   PubMed Web of Science ®Google Scholar
• Alaminos M, Davalos V, Ropero S, et al. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res. 2005;65(7):2565–2571. doi:10.1158/0008-5472.CAN-04-428315805250
   PubMed Web of Science ®Google Scholar
• Fumoto S, Hiyama K, Tanimoto K, et al. EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma. Cancer Lett. 2009;274(1):25–32. doi:10.1016/j.canlet.2008.08.02118823699
   PubMed Web of Science ®Google Scholar
• Yue H, Xu Q, Xie S. High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation. Medicine. 2018;97(1):e9538. doi:10.1097/MD.000000000000953829505529
   PubMed Web of Science ®Google Scholar
• Yasuda H, Lindorfer MA, Myung CS, Garrison JC. Phosphorylation of the G protein gamma12 subunit regulates effector specificity. J Biol Chem. 1998;273(34):21958–21965.9705336
   PubMed Web of Science ®Google Scholar
• Asano T, Morishita R, Matsuda T, Fukada Y, Yoshizawa T, Kato K. Purification of four forms of the beta gamma subunit complex of G proteins containing different gamma subunits. J Biol Chem. 1993;268(27):20512–20519.8376407
   PubMed Web of Science ®Google Scholar
• Luo C, Zhao S, Dai W, Zheng N, Wang J. Proteomic analyses reveal GNG12 regulates cell growth and casein synthesis by activating the Leu-mediated mTORC1 signaling pathway. Biochim Biophys Acta Proteins Proteom. 2018;1866(11):1092–1101. doi:10.1016/j.bbapap.2018.08.01330282607
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu H, Zhang C, Wang Z, Li M, Jiang T. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas. Genes Chromosomes Cancer. 2016;55(2):169–176. doi:10.1002/gcc.2232326542540
   PubMed Web of Science ®Google Scholar
• Palfi S, Swanson KR, De Bouard S, et al. Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer. 2004;91(4):745–752. doi:10.1038/sj.bjc.660204815292940
   PubMed Web of Science ®Google Scholar